A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT01597492 · COMPLETED

Trial details

NCT number: NCT01597492
Sponsor: Human Genome Sciences Inc., a GSK Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2012-05-31
Primary completion: 2015-09-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.